Neuromedin-U
| GO Term | Evidence Code | Reference |
|---|---|---|
| temperature homeostasis | ||
| gastric acid secretion | ||
| positive regulation of systemic arterial blood pressure | ||
| G protein-coupled receptor signaling pathway | ||
| positive regulation of cytosolic calcium ion concentration |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| terminal bouton |
| GO Term | Evidence Code | Reference |
|---|---|---|
| signaling receptor binding | ||
| type 1 neuromedin U receptor binding | ||
| type 2 neuromedin U receptor binding | ||
| neuromedin U receptor binding | ||
| neuromedin U receptor binding |
| Pathway Name | Organism |
|---|---|
| G alpha (i) signalling events | Homo sapiens |
| G alpha (q) signalling events | Homo sapiens |
| Peptide ligand-binding receptors | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:9970 | obesity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026